1. Home
  2. RLMD vs YHGJ Comparison

RLMD vs YHGJ Comparison

Compare RLMD & YHGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • YHGJ
  • Stock Information
  • Founded
  • RLMD 2004
  • YHGJ 1975
  • Country
  • RLMD United States
  • YHGJ United States
  • Employees
  • RLMD N/A
  • YHGJ N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • YHGJ Specialty Chemicals
  • Sector
  • RLMD Health Care
  • YHGJ Industrials
  • Exchange
  • RLMD Nasdaq
  • YHGJ Nasdaq
  • Market Cap
  • RLMD 20.3M
  • YHGJ 21.7M
  • IPO Year
  • RLMD N/A
  • YHGJ 1997
  • Fundamental
  • Price
  • RLMD $0.59
  • YHGJ $0.70
  • Analyst Decision
  • RLMD Buy
  • YHGJ
  • Analyst Count
  • RLMD 3
  • YHGJ 0
  • Target Price
  • RLMD $5.00
  • YHGJ N/A
  • AVG Volume (30 Days)
  • RLMD 206.5K
  • YHGJ 19.4K
  • Earning Date
  • RLMD 08-07-2025
  • YHGJ 09-25-2025
  • Dividend Yield
  • RLMD N/A
  • YHGJ N/A
  • EPS Growth
  • RLMD N/A
  • YHGJ N/A
  • EPS
  • RLMD N/A
  • YHGJ N/A
  • Revenue
  • RLMD N/A
  • YHGJ $17,861,000.00
  • Revenue This Year
  • RLMD N/A
  • YHGJ N/A
  • Revenue Next Year
  • RLMD N/A
  • YHGJ N/A
  • P/E Ratio
  • RLMD N/A
  • YHGJ N/A
  • Revenue Growth
  • RLMD N/A
  • YHGJ 1.21
  • 52 Week Low
  • RLMD $0.24
  • YHGJ $0.43
  • 52 Week High
  • RLMD $3.98
  • YHGJ $1.27
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 44.70
  • YHGJ 43.13
  • Support Level
  • RLMD $0.60
  • YHGJ $0.68
  • Resistance Level
  • RLMD $0.67
  • YHGJ $1.02
  • Average True Range (ATR)
  • RLMD 0.06
  • YHGJ 0.06
  • MACD
  • RLMD -0.00
  • YHGJ -0.01
  • Stochastic Oscillator
  • RLMD 16.42
  • YHGJ 5.26

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About YHGJ Yunhong Green CTI Ltd.

Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.

Share on Social Networks: